Pediatric Exposures Reported to the Toxicology Investigators Consortium, 2010-2015
- PMID: 31464880
- DOI: 10.1097/PEC.0000000000001893
Pediatric Exposures Reported to the Toxicology Investigators Consortium, 2010-2015
Abstract
Background and objective: Poisoning is the leading cause of injury death in pediatric patients. Hospital and provider readiness, including pharmacy stocking, depends on reliable surveillance data describing local patterns of age-specific clinically significant exposures and the therapeutic modalities employed in their treatment. We aimed to characterize trends in clinically significant toxic exposures and their management.
Methods: We performed a retrospective review of patients 18 years or younger in the American College of Medical Toxicology's Toxicology Investigators Consortium (ToxIC) Registry, a self-reporting database completed by bedside consulting medical toxicologists. We reviewed cases from January 1, 2010, through December 31, 2015. In 2015, ToxIC included 101 health care facilities. Data collected included demographics, geographic region, encounter and exposure details, survival, and therapeutic modalities employed, including antidotes, antivenoms, gastric decontamination, enhanced elimination, hyperbaric oxygen therapy, and extracorporeal membrane oxygenation.
Results: From 2010 to 2015, 11,616 consults were recorded in ToxIC. Pediatric consultations increased from 934 (23.7%) in 2010 to 2425 (29.9%) in 2015 (P < 0.001). Exposures were most commonly reported in females (57.8%) and adolescents (59.4%). Intentional ingestions (55.5%) comprised the majority of cases. The most frequent agents of exposure were analgesics (21.0%). There were 38 deaths reported (0.9%). The antidote used most commonly was N-acetylcysteine (11.0%). Geographic variation was demonstrated in prevalence of envenomations and heavy metal exposures, their respective treatments, and overall use of decontamination.
Conclusions: Toxicology consultations for pediatric exposures increased from 2010 to 2015. Understanding which pediatric exposures require toxicologist management, the therapies most frequently employed, and geographical patterns is paramount to facility-level planning, pharmacy stocking, and provider education.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Disclosure: G.S.W. receives royalty payments from UpToDate for authorship contributions. The remaining authors declare no conflict of interest.
References
-
- Gummin DD, Mowry JB, Spyker DA, et al. 2016 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th annual report. Clin Toxicol (Phila) . 2017;55:1072–1252.
-
- Calello DP, Henretig FM. Pediatric toxicology: specialized approach to the poisoned child. Emerg Med Clin North Am . 2014;32:29–52.
-
- WISQARS (Web-based Injury Statistics Query and Reporting System). Leading Causes of Death Reports. February 19, 2017. Available at: https://webappa.cdc.gov/sasweb/ncipc/leadcause.html . Accessed January 9, 2018.
-
- WISQARS (Web-based Injury Statistics Query and Reporting System). Leading Causes of Nonfatal Injury. February 19, 2017. Available at: https://www.cdc.gov/injury/wisqars/nonfatal.html . Accessed January 9, 2018.
-
- Mowry JB, Spyker DA, Brooks DE, et al. 2015 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd annual report. Clin Toxicol (Phila) . 2016;54:924–1109.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical